Literature DB >> 9391898

Methionine synthase and neural tube defects.

K Morrison, Y H Edwards, S A Lynch, J Burn, F Hol, E Mariman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9391898      PMCID： PMC1051135          DOI： 10.1136/jmg.34.11.958

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  7 in total

1.  Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium.

Authors:  L E Mitchell
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

2.  Genetic effects on variation in red-blood-cell folate in adults: implications for the familial aggregation of neural tube defects.

Authors:  L E Mitchell; D L Duffy; P Duffy; G Bellingham; N G Martin
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

3.  Cloning, mapping and RNA analysis of the human methionine synthase gene.

Authors:  Y N Li; S Gulati; P J Baker; L C Brody; R Banerjee; W D Kruger
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

4.  Defects in human methionine synthase in cblG patients.

Authors:  S Gulati; P Baker; Y N Li; B Fowler; W Kruger; L C Brody; R Banerjee
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

5.  Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders.

Authors:  D Leclerc; E Campeau; P Goyette; C E Adjalla; B Christensen; M Ross; P Eydoux; D S Rosenblatt; R Rozen; R A Gravel
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

6.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

7.  Homocysteine metabolism in pregnancies complicated by neural-tube defects.

Authors:  J L Mills; J M McPartlin; P N Kirke; Y J Lee; M R Conley; D G Weir; J M Scott
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321
  7 in total
  7 in total

1.  The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother.

Authors:  D C Shields; P N Kirke; J L Mills; D Ramsbottom; A M Molloy; H Burke; D G Weir; J M Scott; A S Whitehead
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 2.  Neural tube defects: prevention by folic acid and other vitamins.

Authors:  A J Copp; N D Greene
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

3.  Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida.

Authors:  Marie-Therese Doolin; Sandrine Barbaux; Maeve McDonnell; Katy Hoess; Alexander S Whitehead; Laura E Mitchell
Journal:  Am J Hum Genet       Date:  2002-10-09       Impact factor: 11.025

Review 4.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

5.  Methionine synthase polymorphisms (MTR 2756 A>G and MTR 2758 C>G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan.

Authors:  Helmi Yousif Al Farra
Journal:  Indian J Hum Genet       Date:  2010-09

Review 6.  Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease.

Authors:  Barbara Troesch; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-12-10       Impact factor: 5.717

Review 7.  Neural tube defects, folic acid and methylation.

Authors:  Apolline Imbard; Jean-François Benoist; Henk J Blom
Journal:  Int J Environ Res Public Health       Date:  2013-09-17       Impact factor: 3.390
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.